Millennium Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24.2M | Buy |
1,257,950
+888,183
| +240% | +$17.7M | 0.02% | 1400 |
|
|
2025
Q4 | $6.1M | Sell |
369,767
-937,404
| -72% | -$15.8M | ﹤0.01% | 2791 |
|
|
2025
Q3 | $19M | Buy |
1,307,171
+406,670
| +45% | +$5.84M | 0.01% | 1715 |
|
|
2025
Q2 | $12.6M | Sell |
900,501
-592,567
| -40% | -$8.34M | 0.01% | 2019 |
|
|
2025
Q1 | $20.3M | Buy |
1,493,068
+1,088,844
| +269% | +$20.9M | 0.02% | 1500 |
|
|
2024
Q4 | $8.24M | Buy |
404,224
+344,056
| +572% | +$8.81M | 0.01% | 2363 |
|
|
2024
Q3 | $1.75M | Sell |
60,168
-559,761
| -90% | -$13.9M | ﹤0.01% | 3820 |
|
|
2024
Q2 | $14.4M | Buy |
619,929
+229,313
| +59% | +$4.4M | 0.01% | 1775 |
|
|
2024
Q1 | $8.02M | Buy |
+390,616
| New | +$7.34M | 0.01% | 2405 |
|
|
2023
Q4 | – | Sell |
-118,351
| Closed | -$2.44M | – | 6223 |
|
|
2023
Q3 | $2.44M | Sell |
118,351
-359,835
| -75% | -$9.13M | ﹤0.01% | 3374 |
|
|
2023
Q2 | $14.1M | Buy |
478,186
+91,897
| +24% | +$2.58M | 0.02% | 1702 |
|
|
2023
Q1 | $8.9M | Buy |
386,289
+89,196
| +30% | +$2.45M | 0.01% | 2078 |
|
|
2022
Q4 | $8.26M | Sell |
297,093
-199,091
| -40% | -$5.92M | 0.01% | 2333 |
|
|
2022
Q3 | $15.2M | Sell |
496,184
-149,152
| -23% | -$4.85M | 0.02% | 1632 |
|
|
2022
Q2 | $19M | Buy |
+645,336
| New | +$16.9M | 0.02% | 1368 |
|
|
2022
Q1 | – | Sell |
-18,360
| Closed | -$819K | – | 7046 |
|
|
2021
Q4 | $819K | Sell |
18,360
-23,482
| -56% | -$1.11M | ﹤0.01% | 4596 |
|
|
2021
Q3 | $2.11M | Buy |
41,842
+22,399
| +115% | +$1.26M | ﹤0.01% | 3843 |
|
|
2021
Q2 | $1.52M | Buy |
19,443
+4,731
| +32% | +$293K | ﹤0.01% | 4250 |
|
|
2021
Q1 | $840K | Buy |
14,712
+8,898
| +153% | +$596K | ﹤0.01% | 4378 |
|
|
2020
Q4 | $487K | Sell |
5,814
-121,874
| -95% | -$7.37M | ﹤0.01% | 4215 |
|
|
2020
Q3 | $4.58K | Buy |
127,688
+105,379
| +472% | +$3.17M | 0.01% | 1928 |
|
|
2020
Q2 | $539K | Buy |
+22,309
| New | +$525K | ﹤0.01% | 3357 |
|
|
2019
Q4 | – | Sell |
-101,659
| Closed | -$1.56M | – | 4296 |
|
|
2019
Q3 | $1.56M | Buy |
+101,659
| New | +$1.94M | ﹤0.01% | 2604 |
|
|
2019
Q2 | – | Sell |
-34,451
| Closed | -$800K | – | 4122 |
|
|
2019
Q1 | $800K | Buy |
+34,451
| New | +$721K | ﹤0.01% | 2998 |
|
|
2018
Q3 | – | Sell |
-171,979
| Closed | -$2.62M | – | 3971 |
|
|
2018
Q2 | $2.62M | Buy |
+171,979
| New | +$3.24M | ﹤0.01% | 2223 |
|
|
2018
Q1 | – | Sell |
-94,316
| Closed | -$1.48M | – | 3717 |
|
|
2017
Q4 | $1.48M | Buy |
+94,316
| New | +$1.7M | ﹤0.01% | 2460 |
|
Other funds holding DNLI
VCM
VPM
